Actin limits enhancement of nanoparticle diffusion through cystic fibrosis sputum by mucolytics
- 1 December 2007
- journal article
- Published by Elsevier in Pulmonary Pharmacology & Therapeutics
- Vol. 20 (6) , 708-717
- https://doi.org/10.1016/j.pupt.2006.08.008
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Anomalous Diffusion Probes Microstructure Dynamics of Entangled F-Actin NetworksPhysical Review Letters, 2004
- Mucus altering agents as adjuncts for nonviral gene transfer to airway epitheliumGene Therapy, 2001
- Drug transfer through mucusAdvanced Drug Delivery Reviews, 2001
- Actin: From Cell Biology to Atomic DetailJournal of Structural Biology, 1997
- Gelsolin Activates DNase Iin Vitroand in Cystic Fibrosis SputumBiochemistry, 1997
- Drug Diffusion through Cystic Fibrotic Mucus: Steady-State Permeation, Rheologic Properties, and Glycoprotein MorphologyJournal of Pharmaceutical Sciences, 1996
- The Polyelectrolyte Nature of F-actin and the Mechanism of Actin Bundle FormationJournal of Biological Chemistry, 1996
- Viscoelastic properties of human tracheobronchial mucin in aqueous solutionBiopolymers, 1995
- Viscoelasticity of F-actin and F-actin/gelsolin complexesBiochemistry, 1988
- Depolymerization of F-actin by deoxyribonuclease ICell, 1976